Live Breaking News & Updates on உயிரியல் ப்ராப்லம்ஸ்
Stay updated with breaking news from உயிரியல் ப்ராப்லம்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers recently found a new species of scale worms (Annelida: Polynoidae) living mostly in pairs with a striking difference compared to the almost 900 already known species of scale worms: one was a quarter the size of its mate. ....
The author of the international bestseller The Sixth Extinction returns to humanity's transformative impact on the environment, now asking: after doing so much damage, can we change nature, this time to save it? Elizabeth Kolbert has become one of the most important writers on the environment. Now she investigates the immense challenges humanity faces as we scramble to reverse, in a matter of decades, the effects we've had on the atmosphere, the oceans, the world's forests and rivers - on the very topography of the globe. In Under a White Sky, she takes a hard look at the new world we are creating. Along the way, she meets biologists who are trying to preserve the world's rarest fish, which lives in a single tiny pool in the middle of the Mojave desert; engineers who are turning carbon emissions to stone in Iceland; Australian researchers who are trying to develop a 'super coral' that can survive on a hotter globe; and physicists who are contemplating shooting t ....
Could an over-the-counter health shot help fight COVID-19? George Mason University researchers think it just might. Cell and Bioscience recently highlighted research led by Yuntao Wu and Ramin Hakami in which they examined the potential anti-coronavirus activities of an over-the-counter drink called Respiratory Detox Shot (RDS). ....
Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses Times Now | Embed The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine after Bharat Biotech s COVAXIN. Biological-E s COVID-19 vaccine, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 clinical trials. ....